PAHC - Company ID 0001069899
The table below shows PHIBRO ANIMAL HEALTH CORP's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $54.93M | $55.49M | $72.77M | $60.35M | $67.07M | $51.84M |
| Short-term investments | $22.52M | $19.02M | $12.50M | $10.00M | $0.00 | $38.00M |
| Receivables | $221.55M | $215.87M | $217.90M | $197.52M | $191.79M | $160.78M |
| Inventory | $539.70M | $517.35M | $471.77M | $448.39M | $427.22M | $272.56M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $894.07M |
| $862.18M |
| $835.80M |
| $776.02M |
| $746.15M |
| $570.77M |
| Property, plant & equipment | $359.27M | $355.38M | $354.78M | $336.09M | $337.66M | $206.31M |
| Goodwill | $59.89M | $59.81M | $59.71M | $54.57M | $54.55M | $54.59M |
| Total assets | $1.45B | $1.41B | $1.39B | $1.32B | $1.29B | $966.29M |
| Accounts payable | $129.64M | $133.30M | $130.60M | $131.62M | $99.44M | $86.53M |
| Total current liabilities | $281.87M | $282.37M | $270.14M | $266.48M | $233.25M | $176.89M |
| Long-term debt | $597.68M | $603.60M | $609.52M | $619.16M | $622.88M | $287.67M |
| Total liabilities | $1.08B | $1.07B | $1.07B | $1.05B | $1.04B | $707.76M |
| Retained earnings | $336.12M | $316.96M | $294.36M | $260.34M | $244.33M | $246.00M |
| Total equity | $361.83M | $332.36M | $311.68M | $265.99M | $246.80M | $258.53M |